Table 3.
Adverse Events | n (%) |
---|---|
• Thrombocytopenia ≥ G4 | 45 (95.7%) |
• Neutropenia ≥ G4 | 47 (100%) |
• Febrile neutropenia | 21 (45%) |
• Anemia ≥ G3 | 45 (95.7%) |
• Infections | 17 (36%) |
• Mucositis | 10 (21%) |
• Tumor lysis syndrome | 0 |
Adverse Events | n (%) |
---|---|
• Thrombocytopenia ≥ G4 | 45 (95.7%) |
• Neutropenia ≥ G4 | 47 (100%) |
• Febrile neutropenia | 21 (45%) |
• Anemia ≥ G3 | 45 (95.7%) |
• Infections | 17 (36%) |
• Mucositis | 10 (21%) |
• Tumor lysis syndrome | 0 |